Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2008
12/23/2008CA2344762C Tests for the rapid evaluation of ischemic states and kits
12/23/2008CA2267665C Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor
12/23/2008CA2249320C Glycosylated humanized b-cell specific antibodies
12/23/2008CA2212750C Humanized antibodies against cd3
12/23/2008CA2158822C Therapeutic agent for rheumatic disease
12/23/2008CA2139515C Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
12/23/2008CA2105300C Process for the development of binding mini-proteins
12/18/2008WO2008154277A1 Process for preparing hypoallergenic and non-allergenic peanuts (arachis hypogaea) utilizing an endopeptidase
12/18/2008WO2008153967A1 Bk1 antagonist conjugates
12/18/2008WO2008153903A2 Heterologous and homologous cellulase expression system
12/18/2008WO2008153722A1 Post-translational regulation of catalytic activities of cytochrome p450 46a1 and uses thereof
12/18/2008WO2008152262A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
12/18/2008WO2008152252A2 Rumc peptides with antimicrobial activity
12/18/2008WO2008151448A1 Engineered versions of polysialyltransferases with enhanced enzymatic properties
12/18/2008WO2008151444A1 Protein production in plants
12/18/2008WO2008151440A1 Modifying glycoprotein production in plants
12/18/2008WO2008151405A1 Expression of fusion proteins containing a single chain antibody fragment linked to elastin-like repeating units in transgenic plants
12/18/2008WO2008131258A3 Pactamycin biosynthetic gene cluster
12/18/2008WO2008131008A3 Protein hydrolysate compositions having improved sensory characteristics and physical properties
12/18/2008WO2008130969A3 Novel compounds
12/18/2008WO2008128973A3 Solutions of mannoproteins and their use
12/18/2008WO2008097829A3 Large scale production of eukaryotic n-acetylglucosaminyltransferase i in bacteria
12/18/2008WO2008073312B1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
12/18/2008WO2008066583A3 Cell-free synthesis of proteins containing unnatural amino acids
12/18/2008WO2008027099A3 Rpa optimization
12/18/2008WO2007146857A8 Anti- mcp-1 antibodies expressed in lemna, compositions, methods and uses
12/18/2008WO2007142667A3 Treatment of patients with autoantibody positive disease
12/18/2008WO2007130535A3 Novel protein fusion/tag technology
12/18/2008WO2007124493A3 Methods and compositions for producing recombinant proteins using a gene for trna
12/18/2008WO2007124327A3 Methods and compositions for expressing negative-sense viral rna in canine cells
12/18/2008WO2007109742A3 Methods for humanizing antibodies and humanized antibodies made thereby
12/18/2008US20080312426 Chicken leukemia inhibitory factor (LIF) and GNNE thereof
12/18/2008US20080312421 Use of A33 antigens and JAM-it
12/18/2008US20080312418 Antibody Specific for Human 4-1BB Receptor
12/18/2008US20080312417 Ucp5
12/18/2008US20080312409 antiapoptosis agents; transduction domains
12/18/2008US20080312178 Human G-Protein Receptor HGBER32
12/18/2008US20080312172 Anti-IL-6 Antibodies, Compositions, Methods and Uses
12/18/2008US20080312158 Semaphorin Gene Family
12/18/2008US20080312146 METH1 and METH2 Polynucleotides and Polypeptides
12/18/2008US20080312143 Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives
12/18/2008US20080312127 Host Cell Comprising a Vector for Production of Proteins Requiring Gamma-Carboxylation
12/18/2008US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12
12/18/2008US20080311654 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
12/18/2008US20080311652 Nucleic acids encoding Melanoma-associated antigen C2 (MAGE-C2); for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring
12/18/2008US20080311625 Immortal Pluripotent Stem Cell Line, Cell Lines Derived Therefrom, Methods of Preparing Thereof and Their Uses
12/18/2008US20080311624 Chimeric immunogens
12/18/2008US20080311623 Plasmid system for multigene expression
12/18/2008US20080311622 Activatable recombinant neurotoxins
12/18/2008US20080311621 Polypeptides and nucleic acids encoding same
12/18/2008US20080311620 Novel Genes
12/18/2008US20080311619 Recombinant Carboxypeptidase B
12/18/2008US20080311599 Antibodies against caspase-8, their preparation and use
12/18/2008US20080311588 nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development; Protein/transcription factor in basic-helix-loop-helix (bHLH) gene family which plays role in cell determination; genetic engineering
12/18/2008US20080311578 System for screening eukaryotic membrane proteins
12/18/2008US20080311242 Variant lipolytic enzymes
12/18/2008US20080311158 Hepatitis C Virus Replication System
12/18/2008US20080311149 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311148 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311144 Mutant forms of cholera holotoxin as an adjuvant
12/18/2008US20080311137 Carcinoembryonic Antigen Fusions and Uses Thereof
12/18/2008US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability
12/18/2008US20080311119 Antibody formulations
12/18/2008US20080311111 Competitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1
12/18/2008US20080311108 Polypeptides
12/18/2008US20080311106 Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use
12/18/2008US20080311102 Nucleic acid molecule that encodes the MGAT-X1 protein; pharmaceutical composition containing the nucleic acid or its expression vector
12/18/2008US20080311094 Isolated Liver Stem Cells
12/18/2008US20080311073 Ilt3 Polypeptides and Uses Thereof
12/18/2008DE102004007658B4 Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen A process for the production of recombinant proteins in eukaryotic host cells
12/18/2008CA2795379A1 Modifying glycoprotein production in plants
12/18/2008CA2700180A1 Modifying glycoprotein production in plants
12/18/2008CA2693084A1 Heterologous and homologous cellulase expression system
12/18/2008CA2690800A1 Protein production in plants
12/18/2008CA2689557A1 Engineered versions of polysialyltransferases with enhanced enzymatic properties
12/18/2008CA2689137A1 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/18/2008CA2684780A1 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
12/17/2008EP2003203A1 Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily
12/17/2008EP2003202A2 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/17/2008EP2003201A2 Compounds and methods for therapy and diagnosis of lung cancer
12/17/2008EP2001358A2 Glycoprotein synthesis and remodeling by enzymatic transglycosylation
12/17/2008EP1572889B1 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
12/17/2008EP1490514A4 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
12/17/2008EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
12/17/2008EP1007673B1 Novel bone mineralization proteins, dna, vectors, expression systems
12/17/2008EP0791067B1 Protein kinase npk-110
12/17/2008EP0737246B1 Bacterial strains of genus bacillus closely phenotypically related to genus lactobacillus, culture method and use
12/17/2008CN101323874A Infrared ray assisted protein rapid enzymolysis method
12/17/2008CN101323859A Construction and transform expression method of human alkaline fibroblast growth factor plant expression vector
12/17/2008CN101323640A Enzymolysis product inhibiting alpha-glucosidase activity and use thereof
12/17/2008CN100443501C Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof
12/17/2008CN100443500C Factor VIII separation
12/17/2008CN100443499C High purity albumin production process
12/16/2008US7465794 genetic engineered RNA viruses that express immunology modulators such as cytokines, chemokines, enzymes, cytokine and chemokine antagonist, surface receptors, adhesion molecule or ligands; genetic vaccines
12/16/2008US7465793 Synthetic Δ17 desaturase derived from Phytophthora ramourum and its use in making polyunsaturated fatty acids
12/16/2008US7465786 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
12/16/2008US7465785 Polypeptide encoded by a nucleic acid over-expressed in melanoma
12/16/2008US7465707 Methods of treatment with TR10 polypeptides
12/16/2008US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury
12/16/2008US7465577 disruption of the newly isolated P. pastoris AMR2 gene encoding beta 1,2-mannosyltransferase